BIOLASE, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Concentrations (Tables)

Concentrations (Tables)

12 Months Ended

Dec. 31, 2015

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the years ended December 31, 2015, 2014 and 2013 are as follows:

		Years Ended December 31,
		2015				2014				2013
Laser systems			67.5		%		61.9		%		68.6		%
Imaging systems			4.6		%		9.0		%		8.2		%
Consumables and other			14.2		%		13.7		%		11.5		%
Services			13.3		%		15.1		%		11.3		%
License fees and royalties			0.4		%		0.3		%		0.4		%
Total revenue			100.0		%		100.0		%		100.0		%